Vyant Bio, Inc. (VYNT)

NASDAQ: VYNT · IEX Real-Time Price · USD
1.20
-0.08 (-6.25%)
At close: Jan 21, 2022 4:00 PM
1.03
-0.17 (-14.17%)
After-hours:Jan 21, 2022 7:55 PM EST

Total Valuation

Vyant Bio has a market cap or net worth of $34.79 million. The enterprise value is $12.58 million.

Market Cap34.79M
Enterprise Value12.58M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Vyant Bio has 28.99 million shares outstanding. The number of shares has increased by 1,059.44% in one year.

Shares Outstanding28.99M
Shares Change (YoY)+1,059.44%
Shares Change (QoQ)+0.00%
Owned by Insiders (%)10.77%
Owned by Institutions (%)10.21%
Float26.71M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio6.98
PB Ratio0.62
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales2.52
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 5.63, with a Debt / Equity ratio of 0.02.

Current Ratio5.63
Quick Ratio5.22
Debt / Equity0.02
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -55.20%, which is considered low. The company has a ROIC of -429.10%.

Return on Equity (ROE)-55.20%
Return on Assets (ROA)-39.00%
Return on Capital (ROIC)-429.10%
Revenue Per Employee$124,650
Profits Per Employee-$494,550
Employee Count40
Asset Turnover0.10
Inventory Turnovern/a

Taxes

Income Tax-8,000
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -75.59% in the last 52 weeks.

Beta (1Y)n/a
52-Week Price Change-75.59%
50-Day Moving Average1.46
200-Day Moving Average2.27
Average Volume (30 Days)138,001

Short Selling Information

Short Interest139,682
Short % of Shares Out0.48%
Short % of Float0.52%
Short Ratio (days to cover)0.93

Income Statement

In the last 12 months, Vyant Bio had revenue of $4.99 million and -19.78 million in losses. Earnings per share was -$1.15.

Revenue4.99M
Gross Profit714,000
Operating Income-16.92M
Pretax Income-19.79M
Net Income-19.78M
EBITDA-17.98M
EBIT-19.44M
Earnings Per Share (EPS)-$1.15
Full Income Statement

Balance Sheet

The company has $23.20 million in cash and $1,000,000 in debt, giving a net cash position of $22.20 million or $0.77 per share.

Cash & Cash Equivalents23.20M
Total Debt1,000,000
Net Cash22.20M
Net Cash Per Share$0.77
Book Value55.92M
Book Value Per Share1.93
Working Capital21.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.79 million and capital expenditures -$471,000, giving a free cash flow of -$16.26 million.

Operating Cash Flow-15.79M
Capital Expenditures-471,000
Free Cash Flow-16.26M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 14.32%, with operating and profit margins of -339.31% and -396.75%.

Gross Margin14.32%
Operating Margin-339.31%
Pretax Margin-396.91%
Profit Margin-396.75%
EBITDA Margin-360.61%
EBIT Margin-389.81%
FCF Margin-326.11%

Dividends & Yields

Vyant Bio does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-56.87%
FCF Yield-46.74%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on October 25, 2019. It was a reverse split with a ratio of 1:30.

Last Split DateOct 25, 2019
Split TypeReverse
Split Ratio1:30